Co-Diagnostics, Inc. (CODX) NASDAQ

0.40

+0.006(+1.53%)

Updated at November 06 01:06PM

Currency In USD

Valuation

Market Cap22.75M
Enterprise Value21.97M
P/E Ratio-0.36
PEG Ratio-0.21
Price/Sales Ratio12.25
Price/Book Ratio0.32
Enterprise/Revenue2.88
Enterprise/EBITDA-0.08

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-35.86
Operating Margin-38.61

Management Effectiveness

Return On Assets-0.77
Return On Equity-0.69

Income Statement

Revenue3.92M
Revenue/Share0.03
Gross Profit2.92M
EBITDA-38.7M
Net Income-37.64M
Diluted EPS-1.24

Balance Sheet

Total Cash13.36M
Total Cash/Share0.4
Total Debt1.7M
Total Debt/Equity0.04
Current Ratio4.12
Book Value Per Share1.24

Price History

52-Week Change-67.6
52-Week High1.55
52-Week Low0.23
Moving Average 50 Days0.4
Moving Average 200 Days0.39

Statistics

Average Volume25.56M
Shares Outstanding31.36M
% Held by Institutions16.08

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A